Anti-CD20 antibodies for primary cutaneous B cell lymphoma: Preliminary results in dermatologic patients;Der anti-CD20-antikörper bei primär kutanen B-zell-lymphomen: Erste erfahrungen in tier clermatologischen anwendung

Hautarzt

Volumn 52, Issue 3, 2001, Pages 205-210

  Gellrich, S ^a   Muche, J M ^a   Pelzer, K ^a   Audring, H ^a   Sterry, W ^a  

^a Asthmapoliklinik   (Germany)

Author keywords

Anti CD20 antibody; Cutaneous B cell lymphoma; Rituximab ; Treatment

Indexed keywords

ALPHA2A INTERFERON; CD20 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; INTERLEUKIN 2; MONOCLONAL ANTIBODY; PREDNISONE; RITUXIMAB; VINCRISTINE;

ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER SURGERY; HUMAN; NONHODGKIN LYMPHOMA; OVARY FOLLICLE CELL; SIDE EFFECT; SKIN LYMPHOMA; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BIOPSY; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; SKIN; SKIN NEOPLASMS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0035106828     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050051291     Document Type: Article

References (15)

1. Treatment of multifocal primary cutaneous B-cell lymphoma: A clinical follow-up study of 29 patients
2. Primary cutaneous marginal B-cell lymphoma: A recently described entity of low grade malignant cutaneous B-cell lymphoma
3. Infection by Borrelia burgdorferi and cutaneous B-cell lymphomas
4. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas
5. Chimeric anti-CD20 (IDEC C2B8) monoclonal antibody sensizes a B cell lymphoma cell line to cell killing by cytotoxic drugs
6. Intralesional therapy with anti-CD20-antibody in primary cutaneous B-cell lymphoma
7. Intralesional cisplatin for the treatment of cutaneous B-cell lymphoma
8. Phase II pilot study of the safety and efficacy of rituximab in combination with CHOP chemotherapy in patients with previously untreated intermediate or high-grade NHL
9. A case of cutaneous B-cell lymphoma treated successfully with MACOP-B
10. Rituximab in patients with low-grade or follikular non-Hodgkin's lymphoma (LG/F NHL): Response rate and duration with a weekly times 8 dosing regime
11. Treatment of primary cutaneous B-cell lymphoma of follicle center cell origin: A clinic follow-up study of 55 patients treated with radiotherapy or polychemotherapy
12. Primary cutaneous B-cell lymphoma. Diagnosis, treatment and prognosis
13. EORTC Classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organiziation for Research and Treatment of Cancer
14. Die Therapie der primären kutanen B-Zell-Lymphome